Recombinant adenoviruses are frequently used as gene transfer vehicles for therapeutic gene delivery. Strategies to amend their tropism include the incorporation of polypeptides with high affinity for cellular receptors. Single-chain antibodies have a great potential to achieve such cell type specificity. In this study, we evaluated the efficiency of incorporation of a single-chain antibody fused with the adenovirus minor capsid protein IX in the capsid of adenovirus type 5 vectors. To this end, the codons for the single-chain antibody fragments (scFv) 13R4 were fused with those encoding of pIX via a 75-Angstrom spacer sequence. The 13R4 is a hyper-stable single-chain antibody directed against b-galactosidase, which was selected for its capacity to fold correctly in a reducing environment such as the cytoplasm. A lentiviral vector was used to stably express the pIX.flag.75.13R4.MYC.HIS fusion gene in 911 helper cells. Upon propagation of pIX-gene deleted human adenovirus-5 vectors on these cells, the pIX-fusion protein was efficiently incorporated in the capsid. Here, the 13R4 scFv was functional as was evident from its capacity to bind its ligand b-galactosidase. These data demonstrate that the minor capsid protein IX can be used as an anchor for incorporation of single-chain antibodies in the capsids of adenovirus vectors.
Introduction
Human adenovirus (HAdV)-derived vectors are among the most frequently used gene delivery vehicles for human gene therapy and vaccination. 1 Much effort has been devoted to improve the cell-type specificity of gene delivery. Whereas the use of bispecific antibodies has been employed with considerable success, retargeting of adenovirus vectors by genetic incorporation of cellspecific ligands and single-chain antibodies proved more difficult. Many attractive ligands for insertion into the virus capsid elements for retargeting purposes are molecules that are normally excreted from the cells, such as epidermal growth factor (EGF), antibodies and their derivatives, for example, single-chain antibody fragments (scFv). 2, 3 An important hurdle is that many of such polypeptide ligands are normally routed via the protein secretory pathway, whereas the adenovirus particles assemble in the nucleus. Hence, the ligands fused with capsid proteins lack the post-translational modifications that may be essential for their function. 2, 4 The reducing environment in the cytoplasm, which prevents the formation of disulfide bridges, and the absence of accessory factors to help these proteins to fold correctly, avert their maturation to functional proteins. 5 Indeed, studies in which scFv were fused with capsid proteins were not very successful. 2, 6, 7 However, some antibodies can be produced in a soluble form in the cytoplasm and retain their activity. These are the called hyper-stable single-chain antibodies. [8] [9] [10] [11] [12] Recently, such hyper-stable scFv have been incorporated in HAdV particles on de-knobbed, fibritin-foldon trimerized fibers. 4 Although the exact location of pIX in the adenovirus capsid is under revision, [13] [14] [15] [16] we and others have shown that this minor protein is an efficient platform for retargeting and imaging moieties. [17] [18] [19] [20] [21] Here, we demonstrate efficient and functional incorporation of the hyper-stable scFv 13R4 that was fused with the minor capsid protein pIX via a 75-Angstrom spacer. The scFv 13R4 originates from a naïve human phage display library 22 and was isolated after random mutagenesis by error-prone polymerase chain reaction, and selection for increased cytoplasmic solubility. 9 We show that 13R4 fused with pIX via the 75-Angstrom spacer is accessible on the surface of purified viruses. Moreover, the 13R4 is functional in the capsid as evidenced from its capacity to bind Escherichia coli b-galactosidase.
Results
For incorporation of the 13R4 scFv in the adenovirus capsid a fusion gene was constructed in which the coding region of pIX was fused via the flag epitope with the codons for a 75-Angstrom spacer, and with the codons for the 13R4 scFv ( Figure 1a) . The resulting fusion gene coding for pIX.flag.75.13R4.MYC.HIS was inserted into the lentiviral expression vector pLV-CMV-IRES-NPTII. 23 A schematic outline of the vector is provided in Figure 1b . No clonal cells were isolated, as the lentiviral transduction leads to a polyclonal cell line that produce homogenous levels pIX, sufficient to restore fully the heat-stable phenotype of the HAdV particle. 23 Immunohistochemistry analysis showed homogeneous amounts of the fusion proteins in the transduced cells (Figure 2a) . The pIX.flag.75.13R4.MYC.HIS amounts produced by the transduced 911 cells are similar to the pIX level produced by 911 cells during infection with a wt HAdV-5 ( Figure 2b) . 23 Next, we tested the incorporation of pIX.flag.75.13R4. MYC.HIS into the capsid of the HAdV-5 vector HAdV5DpIX.CMV.GFP/LUC. 23 This vector lacks a functional pIX gene and carries the enhanced green fluorescent protein (eGFP) and the firefly luciferase (LUC) reporter genes under control of two separate cytomegalovirus (CMV)-promoters. HAdV-5DpIX.CMV.GFP/LUC viruses were propagated on the 911-pIX.flag.75.13R4.MYC.HIS cell line, harvested and purified via the conventional CsCl purification method. During purification, particleassociated pIX molecules were separated from the nonassociated pIX, as variants of pIX that cannot be incorporated into the capsid do not co-purify with the particles of CsCl gradients. 19, 24 To examine the amount of pIX.flag.75.13R4.MYC.HIS in the particles, 5 Â 10 9 CsClgradient purified particles were analyzed by Western analysis (Figure 2c) (Figure 2e) .
To study the functionality of the scFv in the capsid, we assayed the ligand (b-galactosidase)-binding capability of the 13R4 on the surface of the adenovirus. To this end, CsCl purified pIX.flag.75.13R4.MYC.HIS-loaded HAdV5DpIX.CMV.GFP/LUC and wt HAdV-5 were separately mixed with 100 mg b-galactosidase. The viruses were purified using continuous CsCl density gradients to separate free b-galactosidase from the b-galactosidase bound to the 13R4 on the surface of the adenoviral particles. To examine if the 13R4 scFv was able to bind b-galactosidase, both viruses were analyzed by Western analysis ( Figure 3a ) and immunoelectron microscopy ( Figure 3b ). Both assays showed that b-galactosidase was bound specifically to viruses loaded with the 13R4 scFv.
For another approach to study the ligand (b-galactosidase)-binding capability of the 13R4 on the surface of the adenovirus, the pIX.flag.75.13R4.MYC.HIS-loaded HAdV-5DpIX.CMV.GFP/LUC particles were trapped in DAKO IDEIA microwells and incubated with b-galactosidase. The DAKO kit was developed for demonstration of HAdV in clinical specimens. It contains microwell strips pre-coated with an anti-HAdV antibody. After blocking and washing, the particles were exposed to the substrate (ONPG). The lentiviral vectors used in this study are so-called SIN vectors, 35 and contain the Rev-responsive element sequence, 36 the central poly-purine tract (cPPT) 33, 37, 38 and the human hepatitis B virusderived post-transcriptional regulatory element. The encephalomyocarditis virus internal ribosomal entry site (IRES) was obtained from pTM3, 39 the NPTII coding region was isolated from peGFPn2 (Clontech, Leusden, The Netherlands).
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, 25 we can calculate that the concentration of o-nitrophenol formed is 1.85 Â 10 À4 M, with corresponds to 37 nmoles in the sample volume. As the reaction was developed for 1 h, this is the equivalent of 37/60 ¼ 0.61 Miller units. 25 As the E. coli b-galactosidase has a specific activity of 58 000 U/nmole of monomer, there is in the well 0.61/58.000 ¼ 1.05 Â 10 À5 nmoles of monomer, that is 2.6 Â 10 À6 nmoles of b-galactosidase tetramer, or 1.6 Â 10 9 b-galactosidase tetramers. The DAKO wells used to capture the adenoviruses seem to be saturated between 1 Â 10 6 and 5 Â 10 6 viruses (data obtained from Dako Diagnostics; http://www.dako.co.uk/products). This means that about 1.6 Â 10 9 /5 Â 10 6 ¼ 320 to 1.6 Â 10 9 /10 6 ¼ 1600 b-galactosidase tetramers would be bound to each particle. As each particle contains 240 pIX molecules in the capsid, this number suggests that the majority of the inserted scFv is active and accessible in the capsid.
Discussion
Here, we demonstrate the functional incorporation of a hyper-stable scFv (13R4), directed against b-galactosidase, fused with pIX into the adenovirus capsid. To test whether the pIX.flag.75.13R4.MYC.HIS (51.8 kDa) is able to incorporate into the viral capsid a 911 cell line was created that produced the pIX.flag.75.13R4.MYC.HIS These data demonstrate that insertions of ligands up to at least 2.5 times the molecular weight of wt pIX can be incorporated into the capsid without decreasing the incorporation efficiency and without impairing the fiber and penton-base-mediated internalization. Retaining the capacity of the arginine glycine aspartic acid (RGD) motif in the penton-base to bind av integrins may be important for retargeted viruses, and may depend on the ligand used for retargeting.
The 13R4.MYC.HIS fusion protein was located on the surface of the adenovirus capsid as shown by immunoelectronmicroscopy. The number of gold particles on the adenovirus particles appeared to be less than in previous studies using pIX.flag.75.MYC. 19 ,23 This might Adenovirus displaying functional scFv on pIX J Vellinga et al be due to the differences between the antibodies used for detection of the epitopes. Furthermore, the structure of the 13R4 scFv could have impaired the accessibility of the C-terminal HIS epitope. Alternatively, the positively charged HIS tag may have associated with the acidicloop regions of the hexon molecules, making them less accessible to antibodies.
Both by Western analysis and by immunoelectron microscopy, we demonstrated that HAdV5DpIX.CMV.GFP/LUC particles loaded with pIX. flag.75.13R4.MYC.HIS bind b-galactosidase, whereas wt HAdV-5 does not. The detection of b-galactosidase in both assays was carried out using the GAL-13 antibody. This antibody does not recognize denatured or reduced b-galactosidase (data from Sigma-Aldrich; http:// www.sigmaaldrich.com/sigma/datasheet/g8021dat.pdf). Nevertheless, in our Western analysis, we were able to detect b-galactosidase using this antibody. The results of the DAKO IDEIA b-galactosidase binding assay using the HAdV-5DpIX.CMV.GFP/LUC particles loaded with pIX.flag.75.13R4.MYC.HIS show binding of native b-galactosidase tetramers. The capacity to bind b-galactosidase was specific for the particles harboring the pIX.flag.75.13R4.MYC.HIS molecules. We estimated that approximately 320-1600 b-galactosidase tetramers are bound per virus particle. As the particle contains 240 pIX molecules in the capsid, this number suggests that the majority of the inserted scFv is active and accessible in the capsid. This is the first time that it has been shown that pIX can be used as anchor to incorporate large targeting ligands such as the model scFv 13R4 into the HAdV-5 capsid.
Unfortunately, the b-galactosidase cannot be used as receptor on cell surfaces. This makes it difficult to show formally that the scFv can mediate adenovirus retargeting. Future studies using for retargeting biological relevant scFv, such as the scFv-aHER2, 26 will show the applicability of these retargeting moieties. Alternatively, 13R4 can be used as scaffold for loop grafting. 27 Hyper-stable scFv can be produced without the need of stabilizing disulfide bounds. The development of techniques that facilitate the creation of large libraries of hyper-stable scFv will be of great importance for use in therapeutic agents such as gene transfer vectors described in this study. Traditional techniques involve isolation of V H and V L domains to construct scFv from an original hybridoma or in vitro display systems to screen and select for specific scFv that consequently should be tested for their ability to fold into functional scFv in the cytoplasm. Although these techniques have been shown effective for standard scFv, they rarely yield of the hyperstable scFv variants. Other techniques such as intracellular antigen capturing and complementarity determining regions (CDR) grafting are promising approaches to create effective scFv that can be used for retargeting of adenoviruses to specific cells or tissues. [28] [29] [30] The efficient incorporation of the relatively large 13R4.MYC.HIS fusion protein is promising for future retargeting strategies. The fact that the model scFv used in this study is biological active on the surface of the adenovirus is supporting the feasibility of retargeting adenovirus vectors by inserting of scFv that are directed against specific cellular receptors. However, it should be noticed that formal proof of effective retargeting via these pIX modifications still needs to be provided. In this light, it is important to be aware that the efficiency of retargeting can depend on the capsid protein to which the scFv is added. 18 Therefore, it is necessary to compare side by side the retargeting efficiency with a single scFv fused with different capsid proteins (i.e. pIX and fiber).
Methods

Cells
The HAdV-5 E1-transformed cell line 911 31 was maintained at 371C in a humidified atmosphere of 5% CO 2 in Dulbecco's modified Eagle's medium (Gibco-BRL, Breda, The Netherlands) supplemented with 8% fetal bovine serum (Gibco-BRL) and 0.3% glucose (JT Baker, Deventer, The Netherlands). The 911 cells were used to propagate and titer adenovirus vectors. Infections of the cells with HAdVs were carried out in infection medium containing 2% horse serum.
Production of recombinant lentiviruses
The lentiviral vectors used in this study were described in earlier studies. 23 The lentivirus vectors were derived from the plasmid pLV-CMV-eGFP. Plasmid pLV-CMVpIX.flag.75.13R4.MYC.HIS-IRES-NPTII has been constructed by standard cloning procedures. 23 The gene for pIX.flag.75 was obtained from the pCDNA3.1-based construct pAd5pIX.MYC.flag.75.MYC. 19 The gene encoding the scFv 13R4 was subcloned from the plasmid pPM163R4. 9 The lentiviral vectors were produced and quantified as described previously. 23, 32 For titer estimations was assumed that 1 ng p24 equals to 2 Â 10 3 transducing units in an infection assay. 33 
Lentiviral transduction
For transduction, the lentiviral supernatant was added to fresh medium together with 8 mg ml À1 Polybrene (Sigma Aldrich, Zwijndrecht, The Netherlands). After overnight incubation, the medium was replaced with fresh medium. Cells transduced with lentiviral vectors containing the neomycine selection gene were cultured in medium supplemented with 200 mg l À1 G418 (Invitrogen, Breda, The Netherlands).
Adenovirus vectors
The HAdV-CMV.GFP/LUC and HAdV-5DpIX.CMV. GFP/LUC were made as described previously. 19 The vectors carry a GFP and a firefly LUC transgene, each under the control of the human CMV immediate-early promoter. HAdV-5 was obtained from the virus collection of the Department of Molecular Cell Biology of the Leiden University Medical Center. The concentration of the adenovirus particles was measured by a standard OD260 protocol. 34 Heat-inactivation studies of adenoviruses were performed as described previously. 24 
Western analysis
Cell lysates were made in radioimmunoprecipitation assay lysis buffer (50 mM Tris.Cl pH ¼ 7.5, 150 mM NaCl, 0.1% sodium dodecyl sulfate, 0.5% DOC and 1% NP40). Protein concentrations were measured via the standard method with the bicinchoninic acid protein assay (Pierce, Perbio Science BV, Etten-Leur, The Netherlands). Virus lysates were prepared by adding 5 Â 10 9 virus particles directly to Western sample buffer. The Western blotting Adenovirus displaying functional scFv on pIX J Vellinga et al and detection procedures have been previously described. 19, 23 For detection of b-galactosidase, the monoclonal anti-b-galactosidase clone GAL-13 was used (1:2000, Sigma Aldrich, Zwijndrecht, The Netherlands).
Immunohistochemistry assays
For immunohistochemistry assays, the 911-pIX. flag.75.13R4 cells were grown on glass coverslips in sixwells plates, fixed in methanol, washed with phosphatebuffered saline (PBS) containing 0.05% Tween-20, and incubated with primary antibody, anti-flag (anti-FLAG M2 Affinity Gel Freezer-Safe; Sigma Aldrich Chemie, Zwijndrecht, The Netherlands) (1:1000 diluted in PBS, 3% bovine serum albumin (BSA)) for 60 min at room temperature. The cells were washed and incubated with secondary fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse serum (1:100 diluted in PBS, 3% BSA) for 30 min at room temperature. Nuclei were visualized using propidium iodide. Subsequently, the cells were washed and mounted on object glasses using Dabco/ Glycerol (Glycerol, 0.02 M Tris.Cl pH ¼ 8.0 and 1 mg ml À1 2.4-diamidino-2-phenylindole). Cells were visualized with a Leica DM-IRBE microscope.
b-Galactosidase binding
CsCl purified viruses (1 Â 10 11 particles per well) were incubated with 100 mg b-galactosidase (Sigma Aldrich, Zwijndrecht, The Netherlands) for 60 min on room temperature. Subsequently, the viruses were subjected to a continuous CsCl density gradient similar to the standard CsCl density gradient protocol during adenovirus purification. The purified viruses were further analyzed via Western analysis and immunoelectron microscopy.
For the DAKO IDEIA b-galactosidase binding assay purified viruses (5 Â 10 9 particles per well) were trapped together with b-galactosidase (Sigma Aldrich, Zwijndrecht, The Netherlands) on DAKO IDEIA microwell strips (Dako Ltd, Ely, UK). After 60 min incubation on room temperature, the microwell strips were washed eight times according to the IDEIA kit instructions. After adding 60 ml ONPG (stock was 4 mg/ml in sodiumphosphate buffer, pH7.5) (Sigma Aldrich, Zwijndrecht, The Netherlands) and 60 ml Z-buffer (100 mM NaH 2 PO 4 / Na 2 HPO 4 pH 7.5; 10 mM KCl; 1 mM MgSO 4 and 50 mM 2-mercaptoethanol), the reaction was stopped after 60 min by adding 50 ml Na 2 CO 3 (stock was 1 M Na 2 CO 3 ). The ONPG incubations were performed at 371C. The conversion of ONPG as a measurement for b-galactosidase activity was determined by assaying the OD420.
Immunoelectron microscopy
The presence of the modified pIX molecules in the viral capsids and the presence of b-galactosidase on the surface of the viral particles was visualized with antisera and gold-labeled protein-A as described. 19 For the detection of the HIS epitope the penta-HIS antibody was used (QIAGEN Benelux BV, Venlo, The Netherlands) (1:200 diluted in PBS-2% BSA). For detection of b-galactosidase, the same antibody was used as for Western analysis (1:200 diluted in PBS-2% BSA). Subsequently, these samples were fixed in 1.5% glutaraldehyde in cacodylate buffer and negatively stained with 1% uranyl acetate for 15 min. The viruses were examined with a Philips CM-10 transmission electron microscope at 100 kV.
